Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jozo Boras"'
Autor:
Spomenka Ljubić, Mladen Petrovecki, Jozo Boras, Zeljko Metelko, Nikica Car, Zeljko Reiner, Marijana Vučić Lovrenčić
Publikováno v:
Wiener klinische Wochenschrift. 122:159-164
BACKGROUND: The aim of the study was to establish whether increased levels of serum lipoprotein(a) significantly contribute to an increase in intima-media thickness and the number of carotid artery plaques, and consequently to cardiovascular risk in
Publikováno v:
Physiological research. 63(2)
Endogenous secretory receptor (esRAGE) for advanced glycation end-product (AGE) acts as decoy for AGEs. The AGE-to-esRAGE ratio was hypothesized to be implicated in diabetic vasculopathy. We investigated an association of esRAGE and methylglyoxal-add
Autor:
Josipa Kern, Jozo Boras, Mario Šekerija, Silvija Canecki-Varžić, Tamara Poljičanin, Silvije Vuletić, Željko Metelko
Publikováno v:
Collegium antropologicum
Volume 36 supplement 1
Issue 1
Volume 36 supplement 1
Issue 1
This prospective study of 1277 participants investigated patient risk self-assessment, motivation for changes in main determinants of the metabolic syndrome and the impact of community nursing intervention on cardiovascular risk reduction. Observed v
Autor:
Mario Šekerija, Željko Metelko, Jozo Boras, Tamara Poljičanin, Branko Kolarić, Silvije Vuletić
Publikováno v:
Collegium antropologicum
Volume 36 supplement 1
Issue 1
Volume 36 supplement 1
Issue 1
The aim of this study was to determine the 5-year cumulative incidence of self-reported diabetes mellitus in relation to various socioeconomic and lifestyle factors in Croatian adult population. The analysis included 2909 participants of the Croatian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6deb10ca8e6108344cee93e2d959b687
https://www.bib.irb.hr/548157
https://www.bib.irb.hr/548157
Publikováno v:
Scopus-Elsevier
Purpose: To compare the antihyperglycemic effects of metformin and creatine in recently detected type II diabetics in a short-term clinical study. Methods: In a 14 day simmetrically randomized crossover study, recently detected type II diabetics rece
Autor:
Dubravka Jurisic Erzen, Anamarija Jazbec, Marijana Vučić Lovrenčić, Dean Mileta, Vinko Vidjak, Jozo Boras, Spomenka Ljubić
Publikováno v:
Clinical and investigative medicine. Medecine clinique et experimentale. 32(4)
Purpose: Adiponectin (ApN) is considered to be responsible for reduction of inflammation and is known to be included in lipid metabolism. This study was designed to assess the role of adiponectin in patients with type 1 and type 2 diabetes and to det
Publikováno v:
Lijecnicki vjesnik. 130(1-2)
Diabetes mellitus is characterised by insufficient insulin secretion and/or insufficient utilisation of glucose. It results in hyperglycemia which is the main reason for the development of late complications of diabetes mellitus. Postprandial hypergl
Autor:
Jozo Boras, Ivana Kovacevic, Vipin Arora, Lea Smircic-Duvnjak, Zeljko Metelko, Velmir Profozic, Matthias Herz
Publikováno v:
Diabetes Research and Clinical Practice. 50:43-44
Autor:
Aganovic I; Internal Clinic, Zagreb Clinical Hospital Center, School of Medicine, University of Zagreb,, Croatia Jozo Boras.
Publikováno v:
EJIFCC [EJIFCC] 2003 Jul 03; Vol. 14 (2), pp. 74-77. Date of Electronic Publication: 2003 Jul 03 (Print Publication: 2003).